Seminars in Oncology
Volume 30, Issue 5 , Pages 562-566, October 2003

The case for a biologically based classification of prostate cancer

  • Christopher J Logothetis

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Christopher J. Logothetis, MD, Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    • Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Abstract 

It is axiomatic that integrated multidisciplinary therapy based on the understanding of malignancy is required for the cure of adult cancer. In successful examples, agents (chemotherapy, biologics) and other modalities (radiation, surgery) are applied on the basis of clinical biology. The understanding of the clinical biology and the development of a classification based on relevant clinical and biological features is central to therapy development.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0093-7754(03)00357-9

doi:10.1016/S0093-7754(03)00357-9

Seminars in Oncology
Volume 30, Issue 5 , Pages 562-566, October 2003

Article Tools

* Image Usage & Resolution